|
This market report appraises the state and potential of the genomics technologies market allowing you to see where the trends are taking us for 2009.
The integration of genomics is poised and projected to revolutionize drug development, industrial biotechnology and alternative energy! These inimitable, next-generation technologies are currently offering ground-floor insight and opportunity in areas that have thwarted science and frustrated researchers for decades.
With the The BioWorld Genomics Technologies Report: Advances and Challenges in RNAi, Stem Cells and Synthetic Biology, you will be able to:
- Get a competitive overview of the primary genomics markets!
- View trends and gainful opportunities in gene therapy, biofuels and investment ventures!
- Understand government agendas shaping the genomics space in 2008 and beyond!
- Find potential partners, licensing and marketing opportunities!
The BioWorld Genomics Technologies Report: Advances and Challenges in RNAi, Stem Cells and Synthetic Biology is priced at $599, plus $17.95 in shipping and handling.
The publishers of BioWorld Today have just released The BioWorld Genomics Technologies Report: Advances and Challenges in RNAi, Stem Cells and Synthetic Biology. This report provides a comprehensive analysis of the markets that are at the forefront of emerging R&D today and likely to be among society s most essential dynamics in the future.
Highlights of this report include:
- Industry Overview — Learn about the history of the technology, recent developments and the challenges ahead.
- Companies — Current and extensive profiles of more than 50 companies, including key personnel, financial history, product development, agreements, licensing arrangements and partners.
- Sectors/Technologies — siRNA, dsRNA, mRNA and eRNA technologies; predictive medicine; personalized medicine; research tools, kits and reagents, pharmacogenomics, stem cells, synthetic biology and DNA applications!
- Market Forecasts/Industry Data — Charts and graphs with market forecasts from 2008 to 2014. Comparisons of key companies' clinical trials. Global R&D activity and more!
- Therapeutic Applications and Results — Analysis of current applications and chronology of clinical trials and historical advancements.
By combining more than 200 pages of analysis on these genomics-based sectors,
The BioWorld Genomics Technologies Report: Advances and Challenges in RNAi, Stem Cells and Synthetic Biology provides the perfect resource for understanding the current state and future of the emerging companies, trends and opportunities in the market.
People who need this report:
- Biotechnology and pharmaceutical executives
- Analysts and investors
- Attorneys and patent officers
- Research and development directors
- Technology transfer officers
- Policy makers
The BioWorld Genomics Technologies Report: Advances and Challenges in RNAi, Stem Cells and Synthetic Biology can be purchased in print or PDF.
To view the table of contents, click here.
|
Print and PDF Version:
|
|
Report-Only Price: $599 + $17.95 s&h
|
Order Now
|
|
